Porth Ymchwil

Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments): Commissioned Report

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

StandardStandard

Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments): Commissioned Report. / Wali, Farhaan.
Commissioned on behalf of Westkin Associates, 2025. 21 t.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

HarvardHarvard

Wali, F 2025, Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments): Commissioned Report. Commissioned on behalf of Westkin Associates.

APA

Wali, F. (2025). Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments): Commissioned Report. Commissioned on behalf of Westkin Associates.

CBE

Wali F 2025. Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments): Commissioned Report. Commissioned on behalf of Westkin Associates. 21 t.

MLA

Wali, Farhaan Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments): Commissioned Report Commissioned on behalf of Westkin Associates. 2025.

VancouverVancouver

Wali F. Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments): Commissioned Report. Commissioned on behalf of Westkin Associates, 2025. 21 t.

Author

Wali, Farhaan. / Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments) : Commissioned Report. Commissioned on behalf of Westkin Associates, 2025. 21 t.

RIS

TY - BOOK

T1 - Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments)

T2 - Commissioned Report

AU - Wali, Farhaan

PY - 2025/2/19

Y1 - 2025/2/19

KW - specialised treatment in India

KW - evere, chronic, or life-threatening conditions

M3 - Commissioned report

BT - Availability of specialised treatment in India for severe, chronic, or life-threatening conditions (regional disparities in access to such treatments)

PB - Commissioned on behalf of Westkin Associates

ER -